Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olmesartan-associated enteropathy: results of a national survey
Lysiane Marthey, Guillaume Cadiot, Philippe Seksik, et al.
Alimentary Pharmacology & Therapeutics (2014) Vol. 40, Iss. 9, pp. 1103-1109
Open Access | Times Cited: 188

Showing 1-25 of 188 citing articles:

Immunologic Effects of the Renin-Angiotensin System
Steven D. Crowley, Nathan P. Rudemiller
Journal of the American Society of Nephrology (2017) Vol. 28, Iss. 5, pp. 1350-1361
Open Access | Times Cited: 143
Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology
N. Burbure, Benjamin Lebwohl, Carolina Argüelles-Grande, et al.
Human Pathology (2015) Vol. 50, pp. 127-134
Closed Access | Times Cited: 125
The clinical and phenotypical assessment of seronegative villous atrophy; a prospective UK centre experience evaluating 200 adult cases over a 15-year period (2000–2015)
Imran Aziz, Mohammad Farhad Peerally, Jodie-Hannah Barnes, et al.
Gut (2016) Vol. 66, Iss. 9, pp. 1563-1572
Open Access | Times Cited: 107
Seronegative celiac disease: Shedding light on an obscure clinical entity
Umberto Volta, Giacomo Caio, Elisa Boschetti, et al.
Digestive and Liver Disease (2016) Vol. 48, Iss. 9, pp. 1018-1022
Open Access | Times Cited: 100
Systematic review: Clinical phenotypes, histopathological features and prognosis of enteropathy due to angiotensin II receptor blockers
Annalisa Schiepatti, Paolo Minerba, Michele Puricelli, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 4, pp. 432-444
Open Access | Times Cited: 15
Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study
Mickaël Basson, M. Mezzarobba, Alain Weill, et al.
Gut (2015) Vol. 65, Iss. 10, pp. 1664-1669
Closed Access | Times Cited: 81
Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy
Sophie Scialom, Georgia Malamut, Bertrand Meresse, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0125024-e0125024
Open Access | Times Cited: 71
Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings
Eun-Young Choi, Barbara J. McKenna
Archives of Pathology & Laboratory Medicine (2015) Vol. 139, Iss. 10, pp. 1242-1247
Closed Access | Times Cited: 66
Mosaic theory revised: inflammation and salt play central roles in arterial hypertension
Felicitas E. Hengel, Jean‐Pierre Bénitah, Ulrich Wenzel
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 5, pp. 561-576
Open Access | Times Cited: 32
Clinical and Histologic Mimickers of Celiac Disease
Amrit K. Kamboj, Amy S. Oxentenko
Clinical and Translational Gastroenterology (2017) Vol. 8, Iss. 8, pp. e114-e114
Open Access | Times Cited: 62
A Case of Severe Sprue-Like Enteropathy Associated With Valsartan
Margot L. Herman, Alberto Rubio–Tapia, Tsung‐Teh Wu, et al.
ACG Case Reports Journal (2015) Vol. 2, Iss. 1, pp. 92-94
Open Access | Times Cited: 61
Immunopathogenesis of olmesartan‐associated enteropathy
Eric Marietta, Ashley Nadeau, Amanda K. Cartee, et al.
Alimentary Pharmacology & Therapeutics (2015) Vol. 42, Iss. 11-12, pp. 1303-1314
Open Access | Times Cited: 60
Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review
Ayesha Kamal, Christopher Fain, Angela Park, et al.
Gastroenterology report (2019) Vol. 7, Iss. 3, pp. 162-167
Open Access | Times Cited: 53
Autoimmune enteropathies
Sarah E. Umetsu, Ian Brown, Cord Langner, et al.
Virchows Archiv (2017) Vol. 472, Iss. 1, pp. 55-66
Closed Access | Times Cited: 47
Drug-Induced Enteropathy
Eric Marietta, Amanda K. Cartee, Abdul Rishi, et al.
Digestive Diseases (2015) Vol. 33, Iss. 2, pp. 215-220
Closed Access | Times Cited: 43
Effects of Drugs and Excipients on Hydration Status
Ana M. Puga, Sara Lopez-Oliva, Carmen Trives, et al.
Nutrients (2019) Vol. 11, Iss. 3, pp. 669-669
Open Access | Times Cited: 42
Collagenous Enteritis is Unlikely a Form of Aggressive Celiac Disease Despite Sharing HLA-DQ2/DQ8 Genotypes
Vanderlene L. Kung, Ta‐Chiang Liu, Changqing Ma
The American Journal of Surgical Pathology (2018) Vol. 42, Iss. 4, pp. 545-552
Closed Access | Times Cited: 41
Diagnosis of Seronegative and Ultrashort Celiac Disease
Umberto Volta, Kamran Rostami, Renata Auricchio, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 104-115
Closed Access | Times Cited: 4
Celiac Disease and Other Causes of Duodenitis
Daniel R. Owen, David Owen
Archives of Pathology & Laboratory Medicine (2017) Vol. 142, Iss. 1, pp. 35-43
Open Access | Times Cited: 38
Use of olmesartan and enteropathy outcomes: a multi‐database study
Yaa‐Hui Dong, Yinzhu Jin, Theodore Tsacogianis, et al.
Alimentary Pharmacology & Therapeutics (2018) Vol. 47, Iss. 6, pp. 792-800
Open Access | Times Cited: 37
Overview in the clinical management of patients with seronegative villous atrophy
Annalisa Schiepatti, David S. Sanders, Martina Zuffada, et al.
European Journal of Gastroenterology & Hepatology (2018) Vol. 31, Iss. 4, pp. 409-417
Closed Access | Times Cited: 37
Angiotensin receptor blocker use and gastro‐oesophageal cancer survival: a population‐based cohort study
John Busby, Úna C. McMenamin, Andrew D. Spence, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 47, Iss. 2, pp. 279-288
Open Access | Times Cited: 34
Performing routine follow‐up biopsy 1 year after diagnosis does not affect long‐term outcomes in coeliac disease
Henna Pekki, Kalle Kurppa, M Mäki, et al.
Alimentary Pharmacology & Therapeutics (2017) Vol. 45, Iss. 11, pp. 1459-1468
Open Access | Times Cited: 32
Potential coeliac disease markers and autoimmunity in olmesartan induced enteropathy: A population-based study
María Esteve, Rocío Temiño, Anna Carrasco, et al.
Digestive and Liver Disease (2015) Vol. 48, Iss. 2, pp. 154-161
Closed Access | Times Cited: 31
Olmesartan-Induced Enteropathy
Abimbola Adike, Juan E. Corral, David A. Rybnicek, et al.
Methodist DeBakey Cardiovascular Journal (2016) Vol. 12, Iss. 4, pp. 230-230
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top